Cytyc’s stockholders have approved a merger with the Bedford, Mass.-based Hologic, a medical imaging company. More than 76 percent of the outstanding shares of the Marlborough, Mass.-based Cytyc were voted in favor of the transaction at the special meeting, the company said
The firms entered into a definitive agreement to combine the two companies in a cash and stock transaction announced in May.
Under the terms of the transaction, Cytyc stockholders would receive 0.52 shares of Hologic common stock and $16.50 in cash for each share of Cytyc common stock they own for a total consideration of approximately $6.2 billion.
The transaction is scheduled to close early next week.